Jia Xia

1.2k total citations
29 papers, 422 citations indexed

About

Jia Xia is a scholar working on Molecular Biology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jia Xia has authored 29 papers receiving a total of 422 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 6 papers in Genetics and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jia Xia's work include Ginseng Biological Effects and Applications (3 papers), RNA Interference and Gene Delivery (3 papers) and Prostate Cancer Treatment and Research (3 papers). Jia Xia is often cited by papers focused on Ginseng Biological Effects and Applications (3 papers), RNA Interference and Gene Delivery (3 papers) and Prostate Cancer Treatment and Research (3 papers). Jia Xia collaborates with scholars based in China, United States and France. Jia Xia's co-authors include Fei Tang, Cheng Peng, Jiaojiao Wu, Yingjie Xu, Li Zhang, Lu Chen, Wen Yang, Jinfeng Xu, Yan Wan and Yang Yu and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of the American Society of Nephrology and Frontiers in Immunology.

In The Last Decade

Jia Xia

27 papers receiving 416 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jia Xia China 13 257 77 70 48 48 29 422
Dan Su China 12 324 1.3× 84 1.1× 72 1.0× 40 0.8× 67 1.4× 22 459
Lingling Duan China 12 357 1.4× 64 0.8× 54 0.8× 45 0.9× 85 1.8× 19 546
E. Aaron Runkle United States 9 348 1.4× 158 2.1× 32 0.5× 52 1.1× 79 1.6× 10 600
Bo Tan China 13 220 0.9× 130 1.7× 83 1.2× 58 1.2× 102 2.1× 28 441
Shekoufeh Almasi Canada 12 217 0.8× 59 0.8× 21 0.3× 40 0.8× 53 1.1× 19 436
Tao Liang China 14 278 1.1× 90 1.2× 48 0.7× 49 1.0× 76 1.6× 38 610
Gamze Ayaz United States 9 238 0.9× 49 0.6× 153 2.2× 30 0.6× 69 1.4× 12 466

Countries citing papers authored by Jia Xia

Since Specialization
Citations

This map shows the geographic impact of Jia Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jia Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jia Xia more than expected).

Fields of papers citing papers by Jia Xia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jia Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jia Xia. The network helps show where Jia Xia may publish in the future.

Co-authorship network of co-authors of Jia Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Jia Xia. A scholar is included among the top collaborators of Jia Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jia Xia. Jia Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xia, Jia, Jie Wang, Jiahui Zhang, et al.. (2025). Repair of Isoaspartyl Residues by PCMT1 and Kidney Fibrosis. Journal of the American Society of Nephrology. 36(7). 1278–1294. 3 indexed citations
2.
He, Xiahong, et al.. (2025). An overview of current research on the modulation of NLRP3 inflammasome by traditional Chinese medicine to combat acute pancreatitis. Frontiers in Molecular Biosciences. 12. 1634132–1634132.
3.
Dong, Keqin, Jie Ding, Jia Xia, et al.. (2024). CRISPR genome-wide screening identifies PAK1 as a critical driver of ARSI cross-resistance in prostate cancer progression. Cancer Letters. 587. 216725–216725. 8 indexed citations
4.
Zhang, Li, et al.. (2024). New perspectives on the therapeutic potential of quercetin in non-communicable diseases: Targeting Nrf2 to counteract oxidative stress and inflammation. Journal of Pharmaceutical Analysis. 14(6). 100930–100930. 46 indexed citations
5.
Wu, Jiaojiao, Li Zhang, Jia Xia, et al.. (2023). Ginsenoside Rg1, lights up the way for the potential prevention of Alzheimer's disease due to its therapeutic effects on the drug-controllable risk factors of Alzheimer's disease. Journal of Ethnopharmacology. 318(Pt B). 116955–116955. 7 indexed citations
6.
Xia, Jia, Yutong Hou, Yingjie Xu, et al.. (2023). An integrated co-expression network analysis reveals novel genetic biomarkers for immune cell infiltration in chronic kidney disease. Frontiers in Immunology. 14. 1129524–1129524. 11 indexed citations
7.
Zhang, Yu, Jia Xia, Yanan Yin, et al.. (2023). The Screening of Broadly Neutralizing Antibodies Targeting the SARS-CoV-2 Spike Protein by mRNA Immunization in Mice. Pharmaceutics. 15(5). 1412–1412.
8.
Zhang, Jingjing, Yun Li, Hua Liu, et al.. (2022). Genome-wide CRISPR/Cas9 library screen identifies PCMT1 as a critical driver of ovarian cancer metastasis. Journal of Experimental & Clinical Cancer Research. 41(1). 24–24. 40 indexed citations
9.
Xia, Jia, Jiahui Zhang, Hailong Liu, et al.. (2021). Non-apoptotic function of caspase-8 confers prostate cancer enzalutamide resistance via NF-κB activation. Cell Death and Disease. 12(9). 833–833. 14 indexed citations
10.
Xu, Jinfeng, Yan Wan, Fei Tang, et al.. (2021). Emerging Significance of Ginsenosides as Potentially Reversal Agents of Chemoresistance in Cancer Therapy. Frontiers in Pharmacology. 12. 720474–720474. 12 indexed citations
11.
Li, Qun, Jianglong Lu, Jia Xia, Min Wen, & Chengde Wang. (2019). Long non-coding RNA LOC730100 enhances proliferation and invasion of glioma cells through competitively sponging miR-760 from FOXA1 mRNA. Biochemical and Biophysical Research Communications. 512(3). 558–563. 17 indexed citations
12.
Lu, Jianglong, Qun Li, Lin Cai, et al.. (2018). RBM17 controls apoptosis and proliferation to promote Glioma progression. Biochemical and Biophysical Research Communications. 505(1). 20–28. 12 indexed citations
13.
Wen, Lu, Qian Pan, Zhi Long, et al.. (2008). Efficient protein expression from the endogenous RNA polymerase I promoter using a human ribosomal DNA targeting vector. Biochemical and Biophysical Research Communications. 367(4). 846–851. 4 indexed citations
14.
Xue, Zhigang, Qian Pan, Lisa Y. Wu, et al.. (2007). Non‐viral ex vivo transduction of human hepatocyte cells to express factor VIII using a human ribosomal DNA‐targeting vector. Journal of Thrombosis and Haemostasis. 5(2). 347–351. 17 indexed citations
15.
Zheng, Duo, Kun Xia, Qian Pan, et al.. (2005). [Splicing site mutation of D19S418 in PRPF-31 gene and its phenotypic characters with autosomal dominant retinitis pigmentosa].. PubMed. 41(11). 1020–6. 2 indexed citations
16.
Wu, Lingqian, Danying Zheng, Hao Deng, et al.. (2004). Confirmation and refinement of a genetic locus for disseminated superficial actinic porokeratosis (DSAP1) at 12q23.2-24.1. British Journal of Dermatology. 150(5). 999–1004. 6 indexed citations
17.
Luo, Wei, et al.. (2003). [Mutation analysis of neurofilament-light gene in Chinese Charcot-Marie-Tooth disease].. PubMed. 20(2). 169–70. 1 indexed citations
18.
Xia, Kun, Hao Deng, Jia Xia, et al.. (2002). A novel locus (DSAP2) for disseminated superficial actinic porokeratosis maps to chromosome 15q25.1-26.1. British Journal of Dermatology. 147(4). 650–654. 32 indexed citations
19.
Li, Xu, et al.. (1997). Assignment of mitotic arrest deficient protein 2 (MAD2L1) to human chromosome band 5q23.3 by in situ hybridization. Cytogenetic and Genome Research. 78(1). 63–64. 22 indexed citations
20.
Xia, Jia, et al.. (1996). [Identification of the origin of 7q+ marker chromosome in a mental retard patient].. PubMed. 29(2). 151–7. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026